logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Charlie Scott

Bayer US LLC

13H指数
60论文数
891被引数
收录论文 29
发表时间
logo
Front Cover封面
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-09-30
err0
errOAAI
errJanet B. McGill; Jennifer B. Green; Hiddo J. L. Heerspink; Johannes F. E. Mann; Amy K. Mottl; Julio Rosenstock; Peter Rossing; Muthiah Vaduganathan; Masaomi Nangaku; Meike Brinker; Charlie Scott; Katja Rohwedder; Li Li; Na Li; Margarida Seco; Rajiv Agarwal
err分享
err收藏
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial同时起始非奈利酮和恩帕格利福辛对白蛋白尿的影响：一项随机CONFIDENCE试验的参与者水平探索性分析，不考虑基线HbA1c水平
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-08-05
err0
errOAAI
errJanet B. McGill; Jennifer B. Green; Hiddo J. L. Heerspink; Johannes F. E. Mann; Amy K. Mottl; Julio Rosenstock; Peter Rossing; Muthiah Vaduganathan; Masaomi Nangaku; Meike Brinker; Charlie Scott; Katja Rohwedder; Li Li; Na Li; Margarida Seco; Rajiv Agarwal
err分享
err收藏
Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysis空气污染暴露对慢性肾脏病和2型糖尿病的影响：一项FIDELITY分析
errAmerican Journal of Preventive Cardiology
IF5.9
err2026-05-17
err0
errOAAI
errSadeer Al-Kindi; Zhuo Chen; Jean-Eudes Dazard; Youssef M.K. Farag; Gerasimos Filippatos; Peter Rossing; Katja Rohwedder; Pedro Rafael Vieira de Oliveira Salerno; Charlie Scott; Zihe Zheng; Sanjay Rajagopalan
err分享
err收藏
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis在2型糖尿病和慢性肾病中，根据基线治疗目标使用非奈利酮的结局：一项FIDELITY分析
errdiabetes, obesity and metabolism
IF0
err2026-04-24
err0
errOAAI
errJoão Sérgio Neves; Ana Rita Leite; Francisco Vasques-Nóvoa; Bertram Pitt; Gerasimos Filippatos; Luis M. Ruilope; Peter Rossing; Stefan D. Anker; Gianluigi Savarese; Charlie A. B. Scott; Andrea Lage; Meike D. Brinker; João Pedro Ferreira
err分享
err收藏
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of CONFIDENCE Randomized Trial使用恩格列净、非格列美酮或两者时的血钾过高风险：CONFIDENCE随机试验的二次分析
errJACC
IF0
err2025-11-07
err0
errOAAI
errRajiv Agarwal; Jennifer B. Green; Hiddo J.L. Heerspink; Janet B. McGill; Amy Mottl; Masaomi Nangaku; Julio Rosenstock; Peter Rossing; Muthiah Vaduganathan; Carolina Solis-Herrera; Charlie Scott; Li Li; Meike Brinke; Carolina Aldworth; Johannes F.E. Mann
err分享
err收藏
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study剂量、治疗模式及非奈利酮在常规治疗中的安全性：一项前瞻性、真实世界和观察性FINE-REAL研究的期中分析
errCLINICAL KIDNEY JOURNAL
IF4.6
err2025-11-01
err0
errOAAI
errWheeler, David C.; Pantalone, Kevin M.; Guo, Lixin; Desai, Nihar R.; Correa-Rotter, Ricardo; Nicholas, Susanne B.; Kim, Nan Hee; Zheng, Zihe; Scott, Charlie; Horvat-Broecker, Andrea; Merz, Martin; Wanner, Christoph; Navaneethan, Sankar D.
err分享
err收藏
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both Post Hoc Analyses of CONFIDENCE Trial基线肾功能、白蛋白尿及尿白蛋白-肌酐比值降低：与Finnerenone、Empagliflozin或两者联合治疗的CONFIDENCE试验事后分析
errJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
IF9.4
err2025-11-01
err0
PREAI
errMottl, Amy; Scott, Charlie; Green, Jennifer B.; Heerspink, Hiddo J. L.; Mann, Johannes F. E.; Mcgill, Janet B.; Nangaku, Masaomi; Rosenstock, Julio; Rossing, Peter; Li, Li; Li, Na; Vaduganathan, Muthiah; Agarwal, Rajiv
err分享
err收藏
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia. Pre-Specified Analysis of CONFIDENCE同时启动非奈利酮和恩帕吉洛芬对亚洲人群尿白蛋白肌酐比值的影响：CONFIDENCE研究的预先指定分析
errCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
IF7.1
err2025-09-01
err2
errOAAI
errAgarwal, Rajiv; Green, Jennifer B.; Heerspink, Hiddo J. L.; Mann, Johannes F. E.; Mcgill, Janet B.; Mottl, Amy; Osonoi, Takeshi; Pal, Atanu; Rossing, Peter; Rosenstock, Julio; Vaduganathan, Muthiah; Li, Li; Li, Na; Scott, Charlie; Manjrekar, Pravin; Yamashita, Satoshi; Nangaku, Masaomi
err分享
err收藏
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trialCONFIDENCE试验中，在不同肾脏风险谱中同时启动finerenone和empagliflozin的治疗。
errNephrology Dialysis Transplantation
IF5.6
err2025-08-01
err0
errOAAI
errVaduganathan, Muthiah; Green, Jennifer B.; Heerspink, Hiddo J. L.; Kim, Sung Gyun; Mann, Johannes F. E.; McGill, Janet B.; Mottl, Amy; Nangaku, Masaomi; Rosenstock, Julio; Rossing, Peter; Li, Li; Li, Na; Rohwedder, Katja; Scott, Charlie; Agarwal, Rajiv
err分享
err收藏
Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis非奈利酮在预设的FIDELITY合并分析中，对于估算肾小球滤过率急性变化患者的疗效与安全性
errKidney International
IF12.6
err2025-04-21
err0
PREAI
errSankar D. Navaneethan; Stefan D. Anker; Gerasimos Filippatos; Bertram Pitt; Peter Rossing; Luis M. Ruilope; Phyllis August; Meike Brinker; Andrea Lage; Luke Roberts; Charlie Scott; Pantelis Sarafidis;
err分享
err收藏
Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
errDIABETES CARE
IF16.6
err2023-12-27
err4
errOAAI
errEbert, Thomas; Anker, Stefan D.; Ruilope, Luis M.; Fioretto, Paola; Fonseca, Vivian; Umpierrez, Guillermo E.; Birkenfeld, Andreas L.; Lawatscheck, Robert; Scott, Charlie; Rohwedder, Katja; Rossing, Peter
err分享
err收藏
Steroidal Mineralocorticoid Receptor Antagonist Treatment Patterns and Predictors of Discontinuation
errCIRCULATION
IF38.6
err2023-11-07
err0
PREAI
errRichard, Emma; Desai, Nihar R.; Willey, Vincent; Gay, Alain; Scott, Charlie; Folkerts, Kerstin; Pessina, Elena; Teng, Chia-Chen; Oberprieler, Nikolaus G.
err分享
err收藏
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysisfinerenone对2型糖尿病，慢性肾脏疾病和肝脂肪变性和纤维化标志物改变的患者的疗效: 保真度亚组分析
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-10-10
err3
errOAAI
errPerakakis, Nikolaos; Bornstein, Stefan R.; Birkenfeld, Andreas L.; Linkermann, Andreas; Demir, Muenevver; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M.; Kolkhof, Peter; Lawatscheck, Robert; Scott, Charlie; Bakris, George L.
err分享
err收藏
Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis
errKIDNEY MEDICINE
IF3.4
err2023-10-01
err0
errOAAI
errRosas, Sylvia E.; Ruilope, Luis M.; Anker, Stefan D.; Pitt, Bertram; Rossing, Peter; Bonfanti, Andres Angelo Cadena; Correa-Rotter, Ricardo; Gonzalez, Fernando; Munoz, Carlos Francisco Jaramillo; Pergola, Pablo; Umpierrez, Guillermo E.; Scalise, Andrea; Scott, Charlie; Lawatscheck, Robert; Joseph, Amer; Bakris, George L.
err分享
err收藏
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial在1型糖尿病和慢性肾脏疾病参与者中研究finerenone的随机III期注册试验的原理和设计: FINE-ONE试验
errDIABETES RESEARCH AND CLINICAL PRACTICE
IF7.4
err2023-10-01
err12
errOAAI
errHeerspink, Hiddo J. L.; Birkenfeld, Andreas L.; Cherney, David Z. I.; Colhoun, Helen M.; Ji, Linong; Mathieu, Chantal; Groop, Per-Henrik; Pratley, Richard E.; Rosas, Sylvia E.; Rossing, Peter; Skyler, Jay S.; Tuttle, Katherine R.; Lawatscheck, Robert; Scott, Charlie; Edfors, Robert; Scheerer, Markus F.; Kolkhof, Peter; McGill, Janet B.
err分享
err收藏
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis
errAMERICAN JOURNAL OF NEPHROLOGY
IF3.2
err2023-09-14
err5
errOAAI
errKoya, Daisuke; Anker, Stefan D.; Ruilope, Luis M.; Rossing, Peter; Liu, Zhihong; Lee, Byung Wan; Lee, Chien-Te; Scott, Charlie; Kolkhof, Peter; Lawatscheck, Robert; Wang, Lili; Joseph, Amer; Pitt, Bertram
err分享
err收藏
Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysis大手术后急性肾损伤患者的慢性肾脏病风险: 美国索赔数据库分析
errCLINICAL KIDNEY JOURNAL
IF4.6
err2023-06-29
err3
errOAAI
errOhlmeier, Christoph; Schuchhardt, Johannes; Bauer, Chris; Brinker, Meike; Kong, Sheldon X.; Scott, Charlie; Vaitsiakhovich, Tatsiana
err分享
err收藏
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study (vol 45, pg 888, 2022)
errDIABETES CARE
IF16.6
err2023-06-13
err0
errOAAI
errRossing, Peter; Burgess, Ellen; Agarwal, Rajiv; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Gillard, Pieter; MacIsaac, Richard J.; Wainstein, Julio; Joseph, Amer; Brinker, Meike; Roessig, Lothar; Scott, Charlie; Bakris, George L.; FIDELIO DKD Investigators
err分享
err收藏
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baselinefinerenone对慢性肾脏疾病和2型糖尿病患者的影响与基线时的HbA1c，HbA1c变异性，糖尿病持续时间和基线时的胰岛素使用无关
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-02-26
err7
errOAAI
errMcGill, Janet B.; Agarwal, Rajiv; Anker, Stefan D.; Bakris, George L.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Birkenfeld, Andreas L.; Caramori, Maria L.; Brinker, Meike; Joseph, Amer; Lage, Andrea; Lawatscheck, Robert; Scott, Charlie; Rossing, Peter; FIDELIO-DKD Investigator; FIGARO-DKD Investigator
err分享
err收藏
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial慢性肾脏病和2型糖尿病伴或不伴心力衰竭患者的Finerenone: fidelio-dkd试验的预设亚组分析
errEUROPEAN JOURNAL OF HEART FAILURE
IF10.8
err2022-05-19
err38
errOAAI
errFilippatos, Gerasimos; Pitt, Bertram; Agarwal, Rajiv; Farmakis, Dimitrios; Ruilope, Luis M.; Rossing, Peter; Bauersachs, Johann; Mentz, Robert J.; Kolkhof, Peter; Scott, Charlie; Joseph, Amer; Bakris, George L.; Anker, Stefan D.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Stefan D. Anker
H 指数: 162 · 论文数: 1.2K
G
George L. Bakris
H 指数: 147 · 论文数: 1.4K
C
Christoph Wanner
H 指数: 135 · 论文数: 1.3K
C
Chantal Mathieu
H 指数: 127 · 论文数: 2.3K
P
Peter Rossing
H 指数: 120 · 论文数: 1.4K
查看更多